These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36282413)

  • 1. Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents.
    Sahoo SK; Ommi O; Maddipatla S; Singh P; Ahmad MN; Kaul G; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
    Mol Divers; 2023 Oct; 27(5):2037-2052. PubMed ID: 36282413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Isoxazole-Carboxylic Acid Methyl Ester Based 2-Substituted Quinoline Derivatives as Promising Antitubercular Agents.
    Kumar Sahoo S; Naiyaz Ahmad M; Kaul G; Nanduri S; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
    Chem Biodivers; 2022 Jul; 19(7):e202200324. PubMed ID: 35653161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationship of new chalcone linked 5-phenyl-3-isoxazolecarboxylic acid methyl esters potentially active against drug resistant Mycobacterium tuberculosis.
    Sahoo SK; Rani B; Gaikwad NB; Ahmad MN; Kaul G; Shukla M; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM
    Eur J Med Chem; 2021 Oct; 222():113580. PubMed ID: 34116324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
    Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
    Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
    Kumar Sahoo S; Maddipatla S; Nageswara Rao Gajula S; Naiyaz Ahmad M; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
    Bioorg Med Chem; 2022 Jun; 64():116777. PubMed ID: 35487101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
    Mao J; Yuan H; Wang Y; Wan B; Pak D; He R; Franzblau SG
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1263-8. PubMed ID: 20022500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
    Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
    Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
    J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis.
    Calixto SD; Simão TLBV; Palmeira-Mello MV; Viana GM; Assumpção PWMC; Rezende MG; do Espirito Santo CC; de Oliveira Mussi V; Rodrigues CR; Lasunskaia E; de Souza AMT; Cabral LM; Muzitano MF
    Bioorg Med Chem; 2022 Jan; 53():116506. PubMed ID: 34890996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
    North EJ; Scherman MS; Bruhn DF; Scarborough JS; Maddox MM; Jones V; Grzegorzewicz A; Yang L; Hess T; Morisseau C; Jackson M; McNeil MR; Lee RE
    Bioorg Med Chem; 2013 May; 21(9):2587-99. PubMed ID: 23498915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
    Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
    J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
    Sulthana MT; Alagarsamy V; Chitra K
    Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
    Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
    Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Quimque MTJ; Go AD; Lim JAK; Vidar WS; Macabeo APG
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
    Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS
    Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.